Literature DB >> 26777544

Case of malignant melanoma that developed the ability to secrete granulocyte colony-stimulating factor.

Yusuke Nakamura1, Kazushi Ishikawa1, Yoshitaka Kai1, Hiromitsu Shimada1, Masanori Kawano2, Tatsuya Iwasaki2, Hiroaki Tagomori2, Kazuhiro Tanata2, Hiroshi Tsumura2, Motoki Arakane3, Haruto Nishida3, Shigeo Yokoyama3, Yutaka Hatano1, Sakuhei Fujiwara1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26777544     DOI： 10.1111/1346-8138.13240

Source DB:  PubMed          Journal:  J Dermatol        ISSN： 0385-2407            Impact factor:   4.005


× No keyword cloud information.
  2 in total

1.  Multiple Phenotypic Conversion in Malignant Melanoma: Obtainment of Granulocyte Colony-Stimulating Factor-Producing Ability during the Intermission of Nivolumab Therapy.

Authors:  Satomi Chujo; Yoshimasa Nobeyama; Akihiko Asahina; Munenari Itoh
Journal:  Case Rep Oncol       Date:  2022-05-30

2.  Paraneoplastic hyperleucocytosis in a melanoma patient after initiation of ipilimumab and nivolumab combination therapy.

Authors:  Thilo Gambichler; E Stockfleth; L Susok
Journal:  J Immunother Cancer       Date:  2018-10-30       Impact factor: 13.751
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.